The surgical tourniquet market was valued at USD 573.40 million in 2025, projected to reach USD 603.22 million in 2026, and is forecast to expand to USD 1001.45 million by 2036 at a 5.2% CAGR. Increasing orthopedic procedure volumes, particularly knee arthroplasty and limb reconstruction surgeries, are sustaining baseline tourniquet consumption across hospital operating rooms. Trauma care protocol standardization in emergency departments is expanding pneumatic tourniquet deployment beyond elective surgical settings into acute hemorrhage control workflows.
Based on FMI's report, the surgical tourniquet sector operates as a consumable and capital equipment hybrid market. Tourniquet cuffs represent the dominant revenue segment as disposable cuff replacement cycles generate recurring procurement volumes tied directly to surgical case counts. Tourniquet systems, comprising pneumatic control units and monitoring displays, contribute capital equipment revenues on longer replacement cycles. Knee arthroplasty procedures account for the largest application share, followed by amputation, plastic surgery, and trauma applications that collectively distribute demand across orthopedic and emergency surgical departments.
Country-level growth trajectories track orthopedic surgical volume expansion and trauma care infrastructure development. China at 7.9% CAGR leads as hospital construction programs embed pneumatic tourniquet systems into new operating room specifications. India follows at 7.7%, driven by expanding joint replacement procedure volumes in private hospital chains. Germany at 6.2% benefits from high orthopedic surgical density and capital equipment refresh cycles. USA at 5.8% and UK at 4.3% sustain steady replacement demand for tourniquet cuffs tied to elective surgery schedules.
| Metric | Details |
|---|---|
| Industry Size (2026) | USD 603.22 million |
| Industry Value (2036) | USD 1001.45 million |
| CAGR (2026 to 2036) | 5.2% |
Source: Future Market Insights, 2026
Surgical Tourniquet encompasses pneumatic limb occlusion devices used to create a bloodless surgical field during orthopedic, trauma, and plastic surgery procedures. The market covers tourniquet cuffs (disposable and reusable bladder assemblies) and tourniquet systems (electronic pneumatic control units with pressure monitoring). Primary applications include knee arthroplasty, limb amputation, reconstructive plastic surgery, and acute trauma hemorrhage control across hospital operating rooms and emergency departments.
Market scope includes global and regional market sizes, a 2026 to 2036 forecast period, segment breakdowns by Product, Application, and regional analysis across North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East and Africa. Pricing trend analysis and competitive positioning assessments are incorporated within the analytical framework.
The scope excludes improvised field tourniquets, elastic bandage tourniquets without pneumatic regulation, and blood pressure cuffs not designed for surgical limb occlusion. Hemostatic agents and surgical drain systems are also excluded.
Modern Technologies and Regulatory Approvals to Drive Growth
A number of public health initiatives have emphasized the importance of controlling bleeding during accidents and trauma in order to reduce mortality and morbidity. As obesity and its associated bariatric surgery prevalence increases, tourniquets are being used to manage blood flow during bariatric surgeries.
In addition to government funding and the development of healthcare infrastructures, the industry is also benefitting from the expansion of healthcare infrastructure.
In clinical settings, tourniquets are approved by regulatory agencies and certified for effectiveness and safety. As tourniquets become more accepted and approved, the industry is expected to grow. The introduction of modern technologies, such as Bluetooth-enabled tourniquets, can also be credited with making the industry more advanced.
Increasing demand for patient-specific tourniquet solutions, which are tailored to individual requirements and needs, is increasing due to their success in improving outcomes.
An increase in postoperative rehabilitation outcomes is associated with the use of tourniquets, particularly in orthopedic and limb surgery. As a result of these positive correlations, their use is increased.
Advanced Trauma Care to Provide Lucrative Opportunities
In recent years, advances in biomedical engineering have improved the ability to customize tourniquet systems according to surgeons and procedures, improving safety and efficiency.
A number of advancements in tourniquet technology have produced improved cuffs capable of creating a safe, low-pressure gradient on the underlying patient limbs, as well as systems capable of applying pressure automatically for a short period of time.
The popularity of aesthetic procedures and best-in-class trauma care drive demand in the market. Through the use of surgery tourniquets, surgeons can minimize perioperative blood loss and optimize antibiotic delivery.
A number of new tourniquet inflation devices, such as S-MART, aim to improve patient safety and reduce complications associated with tourniquet use. Trials and studies with a larger sample size will be conducted in order to prove the efficacy of these products.
Surgical Tourniquets Demand Side Trends
The healthcare industry is evolving, directed by catalysts like population growth, aging population, and innovation in medical technology. Within the industry, the demand for surgical tourniquets upswing as surgical processes become pervasive.
Adherence to regulatory standards is essential in the medical device sector. The vendors should be informed about shifts in rules and standards to warrant that products satisfy the essential needs of new entrants.
Training medical care professionals regarding the advantages and proper adoption of operative tourniquets is vital. The manufacturers can create learning materials or training projects to ensure that users comprehend the best activities and health precautions.
Tourniquet adoption during extremities surgery became widespread in orthopedics, as per a paper published in July 2025 in the Journal of Experimental Orthopedics. Around 90% of surgeons in the United States and the United Kingdom are thought to use tourniquets when doing total knee arthroplasty regularly.
Factors Adversely Affecting Surgical Tourniquet Industry Size Expansion
Economic fluctuations in medical care expenditure impede the growth for the market. The industry players should be prepared to traverse through periods of economic unreliability and modify their strategies correspondingly.
Adherence to strict regulatory standards and shifting guidelines are challenging for vendors functioning in the sector. Compliance with the regulations needs considerable investments in research, development, and quality control procedures.
As with any medical equipment, there are inherent threats related to the implementation of tourniquets in surgeries. The producers invest in extensive liability insurance and administer rigorous quality assurance standards to curb the hazard of product-related occurrences and legal actions.
The industry has witnessed notable growth from 2021 to 2025, ushered by factors like a spur in surgical processes, improvement in medical technology, and surging consciousness regarding patient safety. This period experienced an upsurge in demand, with prominent vendors launching novel products to satisfy the developing requirements of healthcare providers.
Between 2026 and 2036, the demand for surgical tourniquets is on an upward trajectory. Catalysts aiding this growth are the pervasiveness of chronic disorders compelling surgical interventions, proliferating healthcare institutions in developing countries, and an aging population needing surgical interventions.
Developments in surgical procedures and a pressing focus on patient safety augment the adoption of these devices. The soaring investments in healthcare research and development and the launch of advanced tourniquet systems stimulate the growth during the forecast period.
The industry is slated for considerable growth between 2026 and 2036, proffering lucrative opportunities for providers to cash on the evolving demand.
A significant 28.7% share of the global market has been captured by companies in the Tier 1 category. Tourniquets in surgical procedures are part of the product offerings of these well-established medical device companies. With their strong financial positions, distribution channels, and research and development resources, they have an edge in the market.
Their innovative capabilities and ability to meet the diverse needs of customers around the world indicate that they will remain at the forefront. Prominent players include Stryker Corporation and Zimmer Biomet.
Tier 2 companies represent a 34.2% share of the industry is higher than that of tier 1 companies, demonstrating a strong presence overseas and an in-depth understanding of the industry. Surgical tourniquet companies in Tier 2 are specialized in this area.
Quality and innovation must remain at the forefront of this niche sectors. While niche players command a relatively small share of the market, they have a larger reach and financial clout than Tier 1 players. Their specialization and targeted approach enable them to deliver excellent results. Prominent tier 2 players include VBM Medizintechnik and Delfi Medical Innovations.
Most small firms in Tier 3 are regionally dominant and specialize in a narrow range of products. Offering a broad range of surgical products that are tailored to specific customer requirements in order to offer cost-effective solutions.
Players will perform exponentially in the industry if they comply with international standards and stringent regulations. Players include Ulrich Medical, Anetic Aid, Hammarplast Medical, Daesung Maref, OHK Medical Devices, and Dessillons & Dutrillaux.
The section below covers the forecast for emerging markets for surgical tourniquets in terms of countries. Information on key countries in several parts of the globe, including North America, Asia Pacific, Europe, and others, is provided.
The United States is anticipated to remain at the forefront in North America, with a CAGR of 5.8% through 2036. In Asia Pacific region, India experiences a CAGR of 7.7% by 2036.
.webp "Top Country Growth Comparison Surgical Tourniquet Market Cagr (2026 2036)")
| Countries | CAGR 2026 to 2036 |
|---|---|
| United States | 5.8% |
| Germany | 6.2% |
| United Kingdom | 4.3% |
| India | 7.7% |
| China | 7.9% |
The United States is encouraged by modern medical care facilities and a strong demand for innovative healthcare devices. The flourishing consciousness concerning the advantages of minimally invasive surgical methods assists in the growth of the market.
The role of regulatory bodies in governing the surgical tourniquet sector market ushers the adoption of tourniquet technologies in the United States.
The pervasiveness of chronic illnesses and the inclining geriatric population ushered in the demand for the market in the United States. Technological innovations and partnerships among essential vendors advance the industry expansion in the United States.
The market in Germany thrives on a focus on accuracy and quality, indicating the impact of new technologies like artificial intelligence on the market. The strict rules and emphasis on product efficiency direct innovation and expansion in Germany's medical tourniquet market.
Germany experiences growth amplified by a strengthening number of surgeries and proliferating investments in healthcare facilities. The commitment to patient safety and high standards of healthcare delivery in Germany stimulate the growth avenue of the market.
The market in India witnessed steady growth characterized by a proliferating healthcare system and widening medical tourism. The adoption of digital health tech and telemedicine platforms augments the business in India, particularly in remote regions with constrained access to medical care amenities.
The disposable and environmental sustainability concerns catapult the use of the instruments in India. The towering investments in healthcare units and government schemes to encourage medical device production bolster the growth in the market.
The section contains information about the leading segments in the surgical tourniquet industry. In terms of product type category, the tourniquet cuffs segment garners a share of 78.4% by 2036. By application category, the knee arthroplasty segment takes precedence with a share of 33.1% in 2036.
| Segment | Tourniquet Cuffs |
|---|---|
| Value Share (2036) | 78.4% |
Tourniquet cuffs are usually cheaper as compared to complete tourniquet systems, making them widely available and easier to purchase. They are replaced frequently because of wear and hygiene rules, spurring significant sales.
Hospitals and surgical centers prioritize storing tourniquet cuffs because of their vital role and standard demand in surgeries. Cuffs are used with diverse tourniquet systems, improving their flexibility and demand. As the number of surgeries escalates, the demand for tourniquet cuffs also rises, resulting in a steady boom in sales.
| Segment | Knee Replacement |
|---|---|
| Value Share (2036) | 33.1% |
A tourniquet is a widely accepted and effective practice during knee replacement surgery. In addition to preventing blood loss, it improves the visibility of the wound and stops the bleeding. The use of tourniquets during joint arthroplasty surgery further prevents bleeding from resurfaced bones, so bone-implant cementation can proceed more successfully.
Tourniquets may improve the long-term survival of knee implants by reducing bleeding from porous bone ends, thereby improving the bond between the soft cement and the bone. The tourniquet can reduce the frequency of suctioning and reduce complication risk during surgery.
Key surgical tourniquet vendors use promotional and distribution procedures, like direct sales to medical care experts and sales to public health facilities. To keep up with demand globally, surgical tourniquet providers are strengthening their manufacturing capacity.
The majority of the leading producers are not only meeting the demand but also innovating. They are focusing on locating and making advantageous technologies and targeted products from internal as well as external sources.
This active approach is targeted at satisfying the unsatisfied demand in emerging economies, sustaining a positive sense of the industry's future. The manufacturers adopt partnerships and acquisitions as their primary strategies to intensify sales across regions.
Investment Analysis of Specific Surgical Tourniquet Companies
| Company | Stryker Corporation |
|---|---|
| Headquarter | United States |
| Recent Advancement | In February 2025, Stryker announced the acquisition of Vocera Communications, Inc. which is a pioneer in digital care collaboration and communication. |
| Company | Zimmer Biomet |
|---|---|
| Headquarter | United States |
| Recent Advancement | Zimmer Biomet Holdings, Inc. announced the acquisition of Embody, Inc. in January 2025, which is focused on soft tissue healing, for USD 155 million at closing and an additional USD 120 million determined to achieve regulatory and commercial milestones over three years. The acquisition is cumulative to the revenue growth and moderately dilutive to earnings per share. |
| Company | Ulrich GmbH & Co.KG |
|---|---|
| Headquarter | Germany |
| Recent Advancement | Bracco and Ulrich GmbH Co KG, a popular medical device producer specializing in media injectors and spinal implants, announced a long-term partnership in November 2025 that brings a Bracco-branded modern MR injector to the United States. |
| Metric | Value |
|---|---|
| Quantitative Units | USD 603.22 million to USD 1001.45 million, at a CAGR of 5.2% |
| Market Definition | Surgical Tourniquet encompasses pneumatic limb occlusion devices used to create a bloodless surgical field during orthopedic, trauma, and plastic surgery procedures. The market covers tourniquet cuffs... |
| Product Segmentation | Tourniquet cuffs, Tourniquet systems |
| Application Segmentation | Knee arthroplasty, Amputation of limbs, Plastic surgeries, Trauma cases |
| Regions Covered | North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa |
| Countries Covered | China, India, Germany, USA, UK, and 40 plus countries |
| Key Companies Profiled | Stryker Corporation, Zimmer Biomet, Ulrich GmbH & Co.KG, AneticAid Ltd., Hammarplast Medical AB, Anetic Aid, VBM Medizintechnik GmbH, Delfi Medical Innovations, Daesung Maref, OHK Medical Devices, and Dessillons & Dutrillaux |
| Forecast Period | 2026 to 2036 |
| Approach | Forecasting models apply a bottom-up methodology starting with global installed base metrics and projecting the conversion rate to advanced product adoption. |
The industry is bifurcated into tourniquet systems and tourniquet cuffs. The tourniquet systems category is further bifurcated into single channel systems and dual channel systems.
The tourniquet cuffs category is further bifurcated into inflatable cuffs and non-inflatable cuffs. The inflatable cuffs sub-segment in further bifurcated into disposable cuffs and reusable cuffs. The non-inflatable cuffs sub-segment in further bifurcated into disposable cuffs and reusable cuffs
The application category is classified into knee arthroplasty, amputation of limbs, plastic surgeries, and trauma cases.
The end user category is trifurcated into hospitals, ambulatory surgical centers, and specialized clinics.
This bibliography is provided for reader reference. The full Future Market Insights report contains the complete reference list with primary research documentation.
How large is the demand for Surgical Tourniquet in the global market in 2026?
Demand for surgical tourniquet in the global market is estimated to be valued at USD 603.22 million in 2026.
What will be the market size of Surgical Tourniquet in the global market by 2036?
Market size for surgical tourniquet is projected to reach USD 1001.45 million by 2036.
What is the expected demand growth for Surgical Tourniquet between 2026 and 2036?
Demand for surgical tourniquet is expected to grow at a CAGR of 5.2% between 2026 and 2036.
Which Product is poised to lead global sales by 2026?
Tourniquet cuffs accounts for 78.4% share in 2026 as it addresses the primary demand requirements across global markets.
How significant is the role of Knee arthroplasty in driving surgical tourniquet adoption in 2026?
Knee arthroplasty represents 33.1% of segment share as end-user demand consolidates around established application pathways.
What is driving demand in China?
China is projected to grow at a CAGR of 7.9% during 2026 to 2036, driven by expanding infrastructure investment and regulatory modernization.
What does market forecast mean on this page?
The market forecast represents a model-based projection built on defined industry and supply chain assumptions for strategic planning purposes.
How does FMI build and validate the surgical tourniquet forecast?
Forecasting models apply a bottom-up methodology starting with global installed base metrics and cross-validate projections against quarterly industry revenue volumes.
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Surgical Tourniquet Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
